rs187194973

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_022114.4(PRDM16):​c.100G>A​(p.Ala34Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00288 in 1,612,890 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A34V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0018 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0030 ( 11 hom. )

Consequence

PRDM16
NM_022114.4 missense

Scores

6
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 6.85
Variant links:
Genes affected
PRDM16 (HGNC:14000): (PR/SET domain 16) The reciprocal translocation t(1;3)(p36;q21) occurs in a subset of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). This gene is located near the 1p36.3 breakpoint and has been shown to be specifically expressed in the t(1:3)(p36,q21)-positive MDS/AML. The protein encoded by this gene is a zinc finger transcription factor and contains an N-terminal PR domain. The translocation results in the overexpression of a truncated version of this protein that lacks the PR domain, which may play an important role in the pathogenesis of MDS and AML. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01160112).
BP6
Variant 1-3186187-G-A is Benign according to our data. Variant chr1-3186187-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 227857.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-3186187-G-A is described in Lovd as [Benign]. Variant chr1-3186187-G-A is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 281 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PRDM16NM_022114.4 linkuse as main transcriptc.100G>A p.Ala34Thr missense_variant 2/17 ENST00000270722.10
PRDM16NM_199454.3 linkuse as main transcriptc.100G>A p.Ala34Thr missense_variant 2/17

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PRDM16ENST00000270722.10 linkuse as main transcriptc.100G>A p.Ala34Thr missense_variant 2/171 NM_022114.4 P1Q9HAZ2-1

Frequencies

GnomAD3 genomes
AF:
0.00185
AC:
281
AN:
152224
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000651
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00245
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00313
Gnomad OTH
AF:
0.000957
GnomAD3 exomes
AF:
0.00178
AC:
440
AN:
247300
Hom.:
1
AF XY:
0.00178
AC XY:
240
AN XY:
134862
show subpopulations
Gnomad AFR exome
AF:
0.000786
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000335
Gnomad SAS exome
AF:
0.000915
Gnomad FIN exome
AF:
0.00297
Gnomad NFE exome
AF:
0.00282
Gnomad OTH exome
AF:
0.00183
GnomAD4 exome
AF:
0.00299
AC:
4368
AN:
1460548
Hom.:
11
Cov.:
31
AF XY:
0.00292
AC XY:
2120
AN XY:
726572
show subpopulations
Gnomad4 AFR exome
AF:
0.000478
Gnomad4 AMR exome
AF:
0.000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000126
Gnomad4 SAS exome
AF:
0.00114
Gnomad4 FIN exome
AF:
0.00303
Gnomad4 NFE exome
AF:
0.00355
Gnomad4 OTH exome
AF:
0.00225
GnomAD4 genome
AF:
0.00184
AC:
281
AN:
152342
Hom.:
1
Cov.:
33
AF XY:
0.00181
AC XY:
135
AN XY:
74500
show subpopulations
Gnomad4 AFR
AF:
0.000649
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00104
Gnomad4 FIN
AF:
0.00245
Gnomad4 NFE
AF:
0.00313
Gnomad4 OTH
AF:
0.000947
Alfa
AF:
0.00237
Hom.:
0
Bravo
AF:
0.00166
TwinsUK
AF:
0.00324
AC:
12
ALSPAC
AF:
0.00285
AC:
11
ESP6500AA
AF:
0.00115
AC:
5
ESP6500EA
AF:
0.00247
AC:
21
ExAC
AF:
0.00199
AC:
241
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00284
EpiControl
AF:
0.00207

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 19, 2023- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineOct 12, 2017p.Ala34Thr in exon 2 of PRDM16: This variant is not expected to have clinical s ignificance because it has been identified in 0.3% (371/125336) of European chro mosomes by the Genome Aggregation Database Sequencing Project (http://gnomad.bro adinstitute.org; dbSNP rs187194973). ACMG/AMP Criteria applied: BA1 (Richards 20 15). -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
not provided Benign:5
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenFeb 01, 2023PRDM16: BS1, BS2 -
Likely benign, criteria provided, single submitterclinical testingGeneDxDec 15, 2020- -
Likely benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 22, 2023- -
Left ventricular noncompaction 8 Benign:2
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 29, 2024- -
Benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 14, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.46
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.013
T;.;.;T
Eigen
Uncertain
0.19
Eigen_PC
Benign
0.14
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.90
D;D;D;D
M_CAP
Benign
0.071
D
MetaRNN
Benign
0.012
T;T;T;T
MetaSVM
Benign
-0.79
T
MutationAssessor
Uncertain
2.0
.;M;.;M
MutationTaster
Benign
0.93
D;D;D;D;D;D;D
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-0.84
N;N;N;N
REVEL
Benign
0.14
Sift
Uncertain
0.0060
D;D;D;D
Sift4G
Benign
0.34
T;T;T;T
Polyphen
0.92, 0.92
.;P;.;P
Vest4
0.50
MVP
0.47
MPC
0.62
ClinPred
0.028
T
GERP RS
5.1
Varity_R
0.12
gMVP
0.22

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs187194973; hg19: chr1-3102751; COSMIC: COSV54588796; API